News Focus
News Focus
Followers 11
Posts 1489
Boards Moderated 0
Alias Born 07/20/2020

Re: None

Wednesday, 06/25/2025 11:24:50 AM

Wednesday, June 25, 2025 11:24:50 AM

Post# of 642187
NEUP - MC 12m ,Phase 3 data in Q3 for SAD trial and has Alzheimer drug in Phase 2 partnered with pharma giant Merck .this under radar Company has only 1.88 million outstanding shares if we get positive phase 3 data next quarter this going to explode hard .

AFFIRM-1 Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025

a7 nicotinic acetylcholine receptor PAM MK-1167 partnered with Merck and in Phase 2 clinical trial in Alzheimer’s

Cash runway into Q3 2026


Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today